SFA Intervention: Intraluminal or Subintimal? by 怨좎쁺援�
685https://e-kcj.org
ABSTRACT
Subintimal angioplasty (SA) is an endovascular technique to recanalize an occluded 
arterial segment through an extraluminal channel between the intima and media. Since 
its introduction in 1989, the technical success rate has improved with the accumulation 
of procedural experience and the development of retrograde approaches and re-entry 
devices. To date, no randomized trial has compared SA with intraluminal angioplasty (IA) 
for chronic total occlusion (CTO) of the superficial femoral artery (SFA). Based on limited 
data from several registry studies, SA appears to achieve a higher technical success rate than 
IA, whereas mid-term primary patency rates are comparable for both endovascular wiring 
strategies for SFA CTO. Additional clinical data are needed to confirm that SA is as effective 
as IA. The optimal stenting strategy and role of drug-eluting technologies also need to be 
defined to improve SA outcomes.
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INTRODUCTION
Chronic total occlusion (CTO) of the superficial femoral artery (SFA) is a commonly 
encountered target lesion in patients with symptomatic lower extremity arterial disease.1) 
Endovascular treatment of SFA CTO is often challenging because of the lesion length and 
presence of calcification. Bolia et al.2) introduced the subintimal angioplasty (SA) technique 
in 1989; a guidewire is intentionally placed between the intima and media to create a new 
channel for recanalization of the occluded arterial segment. Figure 1 shows a representative 
case of a long SFA occlusion treated with SA and stent implantation. Figure 2 shows 
intravascular ultrasound (IVUS) images taken before and after SA. Although this procedure 
has been widely adopted in the endovascular treatment of lower extremity arterial occlusions, 
the durability of the subintimal channel remains to be proved. No randomized clinical trial 
has compared SA with intraluminal angioplasty (IA) for SFA CTOs. The aim of this review was 
to assess the literature on the immediate and late outcomes of SA versus IA for SFA CTOs.
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Figure 1. A representative subintimal angioplasty case. (A) Baseline angiogram showing superficial femoral artery long 
occlusion. (B) A hydrophilic wire was introduced into subintimal space, and a wire loop was formed by advancing the 
wire into the subintimal channel. (C) Angiogram after pre-dilation. (D) Final angiogram after stent implantation.
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Figure 2. Intravascular ultrasound images of an occluded superficial femoral artery segment before pre-dilation, after pre-dilation, and after stenting. 
S = subintimal channel, TL = occluded true lumen.
TECHNICAL SUCCESS
The early technical success rates of SA were between 74% and 85% in reports published 
before 2000 (Table 1).3-5) For lesions longer than 20 cm, the technical success rate was only 
68%.3) At the time, an antegrade approach from the ipsilateral or contralateral femoral artery 
was the only way to tackle occluded SFA lesions with guidewires, and the subintimal channel 
was dilated with balloons without implanting stents. However, as operators accumulated 
experience and adopted retrograde approaches from distal arteries and using re-entry 
devices, the technical success rate gradually improved (Tables 1 and 2).6-24)
Yilmaz et al.6) reported an 88% success rate in long SFA occlusion (mean length 20.0 cm) 
and used a retrograde approach in 82% of study participants. Soga et al.22) employed a 
bidirectional approach in 37% of the SA group and achieved a technical success rate of 90% 
(mean occlusion length 23.5 cm). Gandini et al.25) attained a 100% success rate using the 
Outback Ltd re-entry catheter (Cordis, Bridgewater, NJ, USA) in patients with TransAtlantic 
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC) II D 
femoropopliteal artery disease compared with a 42.3% success rate with a manual re-entry 
method. A multicenter retrospective study from Korea found a higher technical success rate 
for SA compared to IA.24) Other comparative studies found no difference in the technical 
success rates for the 2 strategies.21)22)24) However, Soga et al.22) reported that 25% of the IA 
cases in their study crossed over to a subintimal approach due to technical difficulties during 
IA. SA also had a significantly shorter procedure time, lesser use of guidewires, body surface 
echography, and IVUS.
PROCEDURAL COMPLICATIONS
Arterial rupture is the most concerning complication associated with SA, but the incidence is 
relatively low, ranging from 0% to 6%. Most arterial ruptures were managed conservatively 
or by endovascular therapy. Although distal embolization was thought to occur less 
frequently in SA than IA due to the absence of atherosclerotic plaques and thrombus in the 
subintimal channel, the incidence is similar to that of IA and varies from 0% to 7.3%. Overall, 
procure-related complication rates do not significantly differ between the 2 endovascular 
strategies.20)22) Only Kim et al.24) reported a higher major complication rate (4.1% vs. 0.4%) 
with SA. However, they still found similar incidence of distal embolizations and arterial 
ruptures for the 2 treatments.
PRIMARY PATENCY
In early studies, the 1-year patency rates for the SA using balloon angioplasty alone in SFA CTOs 
>20 cm varied from 22% to 56%.3)6)26) However, the introduction of self-expanding nitinol 
stents increased the 1-year SA patency rate from 65% to 80%.15)17)19)20)22)26) In a meta-analysis of 37 
studies, the 1-year primary patency rate was 47.9% for SA without stent implantation, 61.6% for 
SA with provisional stenting, and 69.2% for SA with primary stenting.26)
To date, no randomized controlled trial has directly compared SA versus IA for 
femoropopliteal artery disease. One prospective registry study and four retrospective studies 
have compared the immediate and mid-term outcomes for both wire crossing techniques.20-24)
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Antusevas et al.21) reported a higher primary patency rate for SA versus IA. However, the 
baseline clinical and lesion characteristics were different between the 2 groups, and stents 
were rarely used. Other studies found no significant differences between the 2 endovascular 
strategies. Surprisingly, Ishihara et al.23) reported relatively low 1-year patency rates for both 
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Table 1. Summary of published studies on the primary patency of SA for femoropopliteal artery occlusions
First 
author
Study 
design
No. of 
patients/ 
limbs
CLI 
(%)
Lesion 
length 
(cm)
Technical 
success 
(%)
Antegrade/
retrograde 
approach
Reentry 
device Stenting
Primary 
patency Complications
London, 
19943)
Retrospective, 
Single-center
176/200 12 11 80 Antegrade No No 56% (1 year), 
46% (3 years)
Major complication 1%, 
distal emboli 3.5%, 
arterial rupture 2%1)
Reekers, 
19944)
Retrospective, 
single-center
40/40 72.5 16.9 85 Antegrade No No 59% (1 year) Overall 20%, 
distal emboli 0%, 
arterial rupture 0%
McCarthy, 
20005)
Retrospective, 
single-center
66/69 62 10 74 Antegrade No No 51% (6 months) Overall 16%, 
distal emboli 1.5%, 
acute thrombosis 1.5%
Yilmaz, 
20036)
Retrospective, 
single-center
61/67 32.7 20.0 88 Antegrade 18%/ 
retrograde via 
popliteal artery 82%
No 22.0%, BMS 22.0% (1 year) Overall 15%, 
distal emboli 4.5%,  
arterial rupture 6.0%
Laxdal, 
20037)
Retrospective, 
single-center
109/124 35 13 90 Antegrade No No 37% (1 year) Operative mortality 1.8%, 
distal emboli 7.3%
Smith, 
20058)
Retrospective, 
single-center
43/48 35.4 6–10 92 Antegrade/ 
retrograde
No No 53% (1 year) Overall 15%, 
distal emboli 10.4%, 
thrombosis 4.2%
Treiman, 
20069)
Retrospective, 
single-center
29/29 100 N/R 90 Antegrade No All, BMS 85% (1 year), 
64% (2 years)
Overall 13.7%, 
distal emboli 3.4%
Schmieder, 
200810)
Retrospective, 
single-center
368/382 55.8 N/R 87 Antegrade No 22.0%, BMS 50% (1 year) 
for tent group, 
45% (1 year) for 
non-stent group, 
(p=0.73)
Overall 3.2%, 
distal emboli 0.5%, 
arterial rupture 0.5%
Marks, 
200811)
Retrospective, 
single-center
103/116 42 12.7 85 Antegrade 6.9%, 
Outback
77%, BMS 59% (1 year) “Intraoperative 
thrombosis” 6%
Setacci, 
200912)
Retrospective, 
single-center
145/145 100 17.1–22.5 83.5, 96.6 
(using 
Outback)
Antegrade 16.6%, 
Outback
54.5%, BMS, 
spot stenting 43%
70% (1 year), 
34% (3 year)
Overall 6.2%, 
distal emboli 2.1%, 
arterial rupture 2.1%
Köcher, 
201013)
Retrospective, 
single-center
123/133 36.9 11.4 94.5 Antegrade No 2.3%, BMS 67.5% (1 year), 
48.4% (3 year)
Overall 7.9%, 
distal emboli 6%
Siablis, 
20112)
Prospective, 
single-center
98/105 64.3 12.1 91.4 Antegrade 6.6%, 
Outback
70.5%, BMS, 
spot stenting
80.1% (1 year), 
29.0% (3 year)
Overall 11.5%, 
distal emboli 2.9%, 
arterial rupture 3.8%
Hong, 
201315)
Retrospective, 
single-center
150/172 36.0 22.6 94.0 Antegrade 3.5%, 
Outback
All, BMS 77.0% (1 year) Major complication 0%, 
distal emboli 1.2%, 
arterial rupture 2.3
Boufi, 
201316)
Retrospective, 
single-center, 
comparison 
with bypass 
surgery
58/58 53.4 16 93 Antegrade No All, BMS, 
ong stenting
76.9% (1 year), 
64.6% (3 year)
Major complication 5.5%, 
acute thrombosis 1.7%
Hong, 
201517)
Retrospective, 
single-center, 
comparison 
between 
spot vs. long 
stenting
163/196 32, 31 25.8 100 Antegrade 5.1%, 
Outback
All, BMS 87% (1 year), 
77% (2 years) 
for spot stenting; 
56% (1 year), 
47% (2 years) 
for long stenting 
(p<0.001)
Distal emboli 4.6%, 
arterial rupture 1.5%
Tatli, 
201518)
Prospective, 
single-center
74/74 22.0 13.4 97.0 Antegrade No All, BMS, 
long stenting
95% (6 months) Major complication 0%, 
distal emboli 3%, 
arterial rupture 1%
Palena, 
201719)
Prospective, 
single-center
34 100 27.9 100 Antegrade/ 
retrograde (35.3%)
No All, BMS (Supera) 94.1% (1 year) Pseudoaneurysm 14.7%
BMS = bare metal stent; CLI = critical limb ischemia; DES = drug-eluting stent; N/R = not reported; SA = subintimal angioplasty.
techniques despite using drug-eluting stents (DESs; Zilver PTX, Cook Medical, Bloomington, 
IA, USA). This finding may be explained by the limited efficacy of DESs in long lesions. 
Long stenting may have also contributed to the lower patency rates. Hong et al.17) showed that 
primary patency was significantly lower with long stenting than with spot stenting following SA 
of long femoropopliteal occlusions. Thus, stenting strategies may play a more important role 
than the wire passage method in maintaining the patency of recanalized long arterial lesions.
FUTURE PERSPECTIVES
We need more clinical evidence including randomized control trial data to confirm the 
efficacy of SA in SFA occlusions. To date, just one study systematically evaluated guidewire 
location using IVUS to define SA or IA.23) In other reports, wiring strategies were judged by 
guidewire morphology. IVUS is essential to provide objective clinical evidence. Furthermore, 
we need more information regarding the effects of various drug-eluting balloons or stents on 
primary patency of the subintimal channel. The efficacy of dedicated spot stents for primary 
patency after SA will be also an interesting topic to investigate.
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Table 2. Summary of published studies comparing SA and IA for femoropopliteal artery occlusions
First 
author
Study 
design Factor
No. of 
patients/
limbs
CLI 
(%)
Lesion 
length 
(cm)
Technical 
success 
(%)
Retrograde or 
bidirectional 
approach (%)
Reentry 
device 
(%)
Stenting
Stented 
length 
(cm)
Primary 
patency Complications
Ko, 
20071)
Retrospective, 
single-center
SA 52/61 32.8 22.7 95.1 N/R N/R All, BMS 8.0 76.4% (1 year) Major complication 0%, 
distal emboli 0%, 
arterial ruptures 4.9%
IA 54/60 31.6 22.0 86.7 N/R N/R All, BMS 7.5 59.2% (1 year) Major complication 0%, 
distal emboli 6.7%, 
arterial rupture 1.7%
p value 0.11 0.12 0.06
Antusevas, 
200821)
Retrospective, 
single-center
SA 71/73 47.9 12 87.7 N/R N/R 4.1%, BMS N/R 68.5% (1 year), 
65.8% (2 years)
Distal emboli 2.7%, 
arterial rupture 0%
IA 75/75 61.3 6.3 81.3 N/R N/R None - 42.7% (1 year), 
38.7% (2 years)
N/R
p value N/R <0.001
Soga, 
201322)
Retrospective, 
multi-center
SA 189/251 31 23.5 90 36 N/R All, BMS 25.2 68% (1 year), 
53% (3 years)
Overall 13%, 
distal emboli 1%, 
arterial rupture 0%
IA 530/651 31 21.5 91 38 N/R All, BMS 23.1 74% (1 year), 
55% (3 years)
Overall 11%, 
distal emboli 1%, 
arterial rupture 0%
p value 0.71 0.30
Ishihara, 
201623)
Prospective, 
multicenter, 
propensity- 
matched 
comparison, 
IVUS study
SA 61 30 22.0 N/R N/R N/R All, DES 
(ZilverPTX)
N/R 55% (1 year), 
44% (2 years)
Overall 5%
IA 61 25 21.0 N/R N/R N/R All, DES 
(ZilverPTX)
N/R 65% (1 year), 
49% (2 years)
Overall 3%
p value 0.352 (1 year), 
0.648 (2 years)
Kim, 
201824)
Retrospective, 
multicenter
SA 228/243 30.3 25.8 95.1 4.1 12.3 77.1%, BMS 17.3 67.5% (1 year), 
54.0% (2 years)
Major complication 4.1%, 
distal emboli 1.6%, 
arterial rupture 2.9%
IA 233/244 34.8 24.5 89.8 20.1 0 70.3%, BMS 16.5 73.4% (1 year), 
61.3% (2 years)
Major complication 0.4%, 
distal emboli 0.8%, 
arterial rupture 1.6%
p value 0.041 0.086
BMS = bare metal stent; CLI = critical limb ischemia; DES = drug-eluting stent; IA = intraluminal angioplasty; IVUS = intravascular ultrasound; N/R = not reported; 
SA = subintimal angioplasty.
CONCLUSIONS
In the last several decades, new techniques and devices have improved the immediate and 
mid-term outcomes of SA. Based on the currently available data, SA is safe and has a higher 
technical success rate than IA despite its shorter procedure time. The mid-term primary 
patency of SA appears to be comparable with that of IA. An optimal stenting strategy and the 
role of drug-eluting technologies in SA remain to be defined.
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